Nectar Lifesciences' promoters, Mr. Sanjiv Goyal and Sanjiv (HUF), have unpledged a significant 99.46 million shares, representing a total of 44.35% of the company's equity.

This positive development follows the repayment of a company loan, releasing the shares previously held as collateral.

For investors, this move generally reduces perceived financial risk linked to promoter holdings.